{
event: "article_read",
name: `Atopic Dermatitis: How Far Does Treatment Reach?`,
author: ``,
tags: `Immunology | Atopic Dermatitis | Atopic Dermatitis`,
publication_date: ``,
interaction_type: "content"
}
- Article
- Source: Campus Sanofi
Atopic Dermatitis: How Far Does Treatment Reach?
Can treating the skin change what comes next? This edition opens with a 3,525-patient meta-analysis asking whether new and worsening allergic events can be held back, follows infants and young children through two years of continuous treatment, and closes with what 5,279 patients reveal about anti-drug antibodies and whether they matter.
Prevention of Atopic Comorbidities & Atopic March
Attenuating the atopic march: Meta-analysis of the dupilumab atopic dermatitis database for incident allergic events
This meta-analysis of twelve randomized, double-blind, placebo-controlled trials examined the effect of dupilumab on the atopic march in 3,525 patients with atopic dermatitis. Dupilumab treatment significantly reduced the risk of developing new or worsening allergic events, suggesting it may attenuate the progression of allergic disease.
DOI: 10.1016/j.jaci.2022.08.026
MORE THIS MONTH
Related articles
MAT-MY-2600408.V1.Oct 2026